Mark R Miller Selected Research

Mark R Miller Research Topics

Disease

9	Inflammation (Inflammations) 01/2021 - 06/2008
7	Thrombosis (Thrombus) 01/2021 - 08/2014
7	Atherosclerosis 01/2018 - 05/2012
5	Myocardial Infarction 10/2020 - 11/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 07/2012
4	Pneumonia (Pneumonitis) 09/2016 - 12/2010
3	Neoplasms (Cancer) 01/2022 - 09/2016
3	Hypertension (High Blood Pressure) 05/2017 - 06/2013
2	Heart Failure 01/2022 - 01/2013
2	Stroke (Strokes) 01/2022 - 01/2017
2	Vascular Diseases (Vascular Disease) 01/2020 - 06/2019
2	Atherosclerotic Plaque (Atheroma) 08/2017 - 12/2013
2	Pre-Eclampsia (Preeclampsia) 06/2014 - 06/2013
2	Necrosis 02/2014 - 04/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Obesity 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Metaplasia 10/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2019
1	Disseminated Intravascular Coagulation 05/2019
1	Hemorrhage 05/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2018
1	Carotid Artery Diseases 01/2017
1	Lung Diseases (Lung Disease) 09/2016
1	Fetal Weight 05/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 05/2016
1	Dehydration (Water Stress) 12/2014
1	Reperfusion Injury 02/2014
1	Edema (Dropsy) 02/2014
1	Ischemia 02/2014
1	Cardiac Arrhythmias (Arrythmia) 02/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014

Drug/Important Bio-Agent (IBA)

7	Particulate MatterIBA 01/2022 - 06/2008
7	Vehicle Emissions (Emissions, Vehicle)IBA 01/2018 - 12/2010
4	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2012
3	Environmental Pollutants (Pollutants, Environmental)IBA 11/2020 - 11/2011
3	ApolipoproteinsIBA 01/2020 - 05/2012
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2016 - 04/2012
2	Biological ProductsIBA 01/2022 - 05/2012
2	ceric oxide (cerium dioxide)IBA 01/2020 - 05/2012
2	CytokinesIBA 10/2019 - 12/2010
2	GoldIBA 06/2019 - 01/2017
2	Thromboplastin (Tissue Factor)IBA 05/2019 - 01/2018
2	SootIBA 05/2018 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2012
2	LyasesIBA 06/2014 - 06/2013
2	CystathionineIBA 06/2014 - 06/2013
2	EnzymesIBA 06/2014 - 06/2013
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 06/2014 - 06/2013
1	Drinking WaterIBA 01/2022
1	NitratesIBA 01/2022
1	NitritesIBA 01/2022
1	Nitrogen DioxideIBA 01/2022
1	BiofuelsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	OzoneIBA 11/2020
1	Carbon MonoxideIBA 10/2020
1	ZirconiumIBA 01/2020
1	Immunoglobulin G (IgG)IBA 10/2019
1	Immunoglobulin E (IgE)IBA 10/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2019
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2019
1	FibrinIBA 05/2019
1	ThrombomodulinIBA 05/2019
1	antithrombin III-protease complexIBA 05/2019
1	Dacarbazine (DIC)FDA LinkGeneric 05/2019
1	AnticoagulantsIBA 05/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	MicroRNAs (MicroRNA)IBA 05/2017
1	Carbon Nanotubes (Carbon Nanotube)IBA 09/2016
1	DNA (Deoxyribonucleic Acid)IBA 09/2016
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016
1	GlucocorticoidsIBA 05/2016
1	QuartzIBA 02/2016
1	CarbonIBA 02/2016
1	Air Pollutants (Pollutants, Air)IBA 12/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2014
1	BradykininIBA 12/2014
1	SmokeIBA 12/2014
1	BuffersIBA 02/2014
1	TRPV Cation ChannelsIBA 02/2014
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 02/2014
1	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2014
1	Oxidants (Oxidizing Agents)IBA 02/2014
1	AntioxidantsIBA 12/2013
1	LipidsIBA 12/2013
1	propargylglycineIBA 06/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2013
1	Galectin 3 (LGALS3)IBA 06/2013
1	UrocortinsIBA 01/2013
1	Gasoline (Diesel Fuel)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	C-Reactive ProteinIBA 04/2012
1	8-epi-prostaglandin F2alphaIBA 06/2008

Therapy/Procedure

1	Intravenous Injections 02/2016